MB

Mehul Babubhai Shah

Active Director Director DIN 11467372
DIN 11467372 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Mehul Babubhai Shah

Data last updated:

Mehul Babubhai Shah is a Director at Florentis Children's Hospital Private Limited (since 2026) and Designated Partner at Cloud 7 Children's Hospitals Llp (since 2026).

DIN 11467372
Primary Designation Director
First Appointment 06 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jun 20262026Active
Designated Partner06 Jan 20262026Active

Board colleagues of Mehul Babubhai Shah

Directorship timeline

Open interactive timeline →
Cloud 7 Children's Hospitals Llp
Florentis Children's Hospital Private Limited
Premium access

Shareholding and investment profile for Mehul Babubhai Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mehul Babubhai Shah

Mehul Babubhai Shah currently holds 2 directorships: Florentis Children's Hospital Private Limited (Director, since 16 Jun 2026); Cloud 7 Children's Hospitals Llp (Designated Partner, since 06 Jan 2026).

Mehul Babubhai Shah was first appointed on 06 Jan 2026 as Designated Partner at Cloud 7 Children's Hospitals Llp.

The current boards of Mehul Babubhai Shah's companies include Dhavalkumar Dineshkumar Akhani (Florentis Children's Hospital Private Limited), Sumit Ashokkumar Patel (Cloud 7 Children's Hospitals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available